Robot-Assisted Cervical Esophagectomy: a safety and feasibility multicenter trial

Robot-Assisted Cervical Esophagectomy: a safety and feasibility multicenter trial - RACE trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON53416

Enrollment

Registered

2023-06-29

Start date

2024-11-13

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

All included patients will undergo a robot-assisted transcervical esophagectomy with abdominal and low paraesophageal lymphadenectomy, gastric conduit reconstruction and a cervical anastomosis. The

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Histologically proven adenocarcinoma (AC) or squamous cell carcinoma (SCC) of the esophagus or gastroesophageal junction (GEJ) • Unable to undergo a transthoracic approach

Exclusion criteria

Exclusion criteria: • Not able to undergo study treatment.

Design outcomes

Primary

Measure	Time frame
All complications grade 3b and higher as stated by the Clavien-Dindo (CD) classification occurring after RACE.	—

Secondary

Measure	Time frame
All other intraoperative and postoperative complications Oncological outcomes such as resection marges and lymph node yield.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026